Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy

por Lee, Brian, Pierpont, Tim, August, Avery, Richards, Kristy
Publicado 2023

Treatment of Kaposi Sarcoma-Associated Herpesvirus-Associated Cancers

por Dittmer, Dirk P., Richards, Kristy L., Damania, Blossom
Publicado 2012

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy

por Pierpont, Timothy M., Limper, Candice B., Richards, Kristy L.
Publicado 2018

Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells

por Small, George W., McLeod, Howard L., Richards, Kristy L.
Publicado 2013

FLT3 mutations in canine acute lymphocytic leukemia

por Suter, Steven E, Small, George W, Seiser, Eric L, Thomas, Rachael, Breen, Matthew, Richards, Kristy L
Publicado 2011

A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients with High/High-intermediate risk Diffu...

por Reddy, Nishitha M., Greer, John P., Morgan, David S., Chen, Heidi, Park, Steven I., Richards, Kristy L.
Publicado 2016

Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data

por Su, Yuhua, Nielsen, Dahlia, Zhu, Lei, Richards, Kristy, Suter, Steven, Breen, Matthew, Motsinger-Reif, Alison, Osborne, Jason
Publicado 2013

Identifying genes that mediate anthracyline toxicity in immune cells

por Frick, Amber, Suzuki, Oscar T., Benton, Cristina, Parks, Bethany, Fedoriw, Yuri, Richards, Kristy L., Thomas, Russell S., Wiltshire, Tim
Publicado 2015

Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability

por Richards, Kristy L., Zhang, Baili, Baggerly, Keith A., Colella, Stefano, Lang, James C., Schuller, David E., Krahe, Ralf
Publicado 2009

Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia

por Ward, Melea A., Fang, Gang, Richards, Kristy L., Walko, Christine M., Earnshaw, Stephanie R., Happe, Laura E., Blalock, Susan J.
Publicado 2015

Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics

por Frick, Amber, Fedoriw, Yuri, Richards, Kristy, Damania, Blossom, Parks, Bethany, Suzuki, Oscar, Benton, Cristina S, Chan, Emmanuel, Thomas, Russell S, Wiltshire, Tim
Publicado 2015

Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients

por Salahuddin, Sadia, Khan, Jabbar, Azhar, Joharia, Whitehurst, Christopher B., Qadri, Ishtiaq, Shackelford, Julia, Pagano, Joseph S., Muhammad, Dost, Richards, Kristy L.
Publicado 2018

Comprehensive genomic characterization of five canine lymphoid tumor cell lines

por Roode, Sarah C., Rotroff, Daniel, Richards, Kristy L., Moore, Peter, Motsinger-Reif, Alison, Okamura, Yasuhiko, Mizuno, Takuya, Tsujimoto, Hajime, Suter, Steven E., Breen, Matthew
Publicado 2016

Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2(+) diffuse large B-cell lymphomas

por Shen, Yajie, Zhou, Jingqi, Nie, Kui, Cheng, Shuhua, Chen, Zhengming, Wang, Wenhan, Wei, Weiqing, Jiang, Daiji, Peng, Zijing, Ren, Yizhuo, Zhang, Yirong, Fan, Qiuju, Richards, Kristy L., Qi, Yitao, Cheng, Jinke, Tam, Wayne, Ma, Jiao
Publicado 2022

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi

por Gopal, Satish, Fedoriw, Yuri, Kaimila, Bongani, Montgomery, Nathan D., Kasonkanji, Edwards, Moses, Agnes, Nyasosela, Richard, Mzumara, Suzgo, Varela, Carlos, Chikasema, Maria, Makwakwa, Victor, Itimu, Salama, Tomoka, Tamiwe, Kamiza, Steve, Dhungel, Bal M., Chimzimu, Fred, Kampani, Coxcilly, Krysiak, Robert, Richards, Kristy L., Shea, Thomas C., Liomba, N. George
Publicado 2016

Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia

por Cooper, Matthew J., Cox, Nathan J., Zimmerman, Eric I., Dewar, Brian J., Duncan, James S., Whittle, Martin C., Nguyen, Thien A., Jones, Lauren S., Ghose Roy, Sreerupa, Smalley, David M., Kuan, Pei Fen, Richards, Kristy L., Christopherson, Richard I., Jin, Jian, Frye, Stephen V., Johnson, Gary L., Baldwin, Albert S., Graves, Lee M.
Publicado 2013

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

por Nowakowski, Grzegorz S., Hong, Fangxin, Scott, David W., Macon, William R., King, Rebecca L., Habermann, Thomas M., Wagner-Johnston, Nina, Casulo, Carla, Wade, James L., Nagargoje, Gauri G., Reynolds, C. M., Cohen, Jonathon B., Khan, Nadia, Amengual, Jennifer E., Richards, Kristy L., Little, R. F., Leonard, John P., Friedberg, Jonathan W., Kostakoglu, Lale, Kahl, Brad S., Witzig, Thomas E.
Publicado 2021

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

por Batlle-López, Ana, de Villambrosía, Sonia González, Francisco, Mazorra, Malatxeberria, Sefora, Sáez, Anabel, Montalban, Carlos, Sánchez, Lydia, Garcia, Juan F., González-Barca, Eva, López-Hernández, Andrés, Ruiz-Marcellan, MC, Mollejo, Manuela, Grande, Carlos, Richards, Kristy L., Hsi, Eric D., Tzankov, Alexandar, Visco, Carlo, Xu-Monette, Zijun Y., Cao, Xin, Young, Ken H., Piris, Miguel Ángel, Conde, Eulogio, Montes-Moreno, Santiago
Publicado 2016

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

por Ye, Qing, Xu-Monette, Zijun Y., Tzankov, Alexandar, Deng, Lijuan, Wang, Xiaoxiao, Manyam, Ganiraju C., Visco, Carlo, Montes-Moreno, Santiago, Zhang, Li, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Parsons, Ben M., Møller, Michael B., Piris, Miguel A., Winter, Jane N., Medeiros, L. Jeffrey, Hu, Shimin, Young, Ken H.
Publicado 2015

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma

por Zhang, Mingzhi, Xu-Monette, Zijun Y., Li, Ling, Manyam, Ganiraju C., Visco, Carlo, Tzankov, Alexandar, Wang, Jing, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., Han van Krieken, J., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Jeffrey Medeiros, L., Pham, Lan V., Young, Ken H.
Publicado 2016